September 7, 2017 Acad, Gov/Utilities Molecular Spectroscopy Product Launch

New MiniLab EL Series from Spectro Scientific Provides Immediate Oil Analysis for High Performance Engines

(Chelmsford, MA – Thursday, September 7, 2017) The new MiniLab EL Series from Spectro Scientific is a fast, convenient oil analysis tool for non-destructive testing of high performance engines in aircraft, racing cars, and railway environments. Oil analysis is a reliable and mature non-destructive testing technique that is widely used in engine design and development, production quality... Read more

August 30, 2017 Acad, Gov/Utilities

First FDA-Approved Cell Therapy for Leukemia Utilizes Thermo Fisher Scientific's CTS Dynabeads Technology

First FDA-Approved Cell Therapy for Leukemia Utilizes Thermo Fisher Scientific’s CTS Dynabeads Technology Kymriah™ (tisagenlecleucel, formerly CTL019), the first FDA-approved CAR-T cell therapy, uses CTS Dynabeads CD3/CD28 spherical beads to isolate, activate and expand T cells WALTHAM, Mass., Aug. 30, 2017 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved a new cell therapy... Read more

August 30, 2017 Acad, Gov/Utilities Microscopy

FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome

Basel, 30 August 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome Actemra/RoActemra is the first FDA-approved treatment for severe or life-threatening cytokine release syndrome induced by CAR T cell therapy CAR T cell therapy is an immunotherapy designed for the treatment of certain cancers This is the... Read more

August 30, 2017 Acad, Gov/Utilities Microscopy

FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome

Basel, 30 August 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome Actemra/RoActemra is the first FDA-approved treatment for severe or life-threatening cytokine release syndrome induced by CAR T cell therapy CAR T cell therapy is an immunotherapy designed for the treatment of certain cancers This is the... Read more

August 30, 2017 Acad, Gov/Utilities Lab Top-10 Molecular Spectroscopy Product Launch

Shimadzu's New EDX-8100 Energy Dispersive X-Ray Fluorescence Spectrometer Enables Analysis of Liquid Samples with High Sensitivity by Helium Purging

Energy dispersive X-ray fluorescence (ED-XRF) spectrometers can analyze the composition and concentration of elements contained in samples by detecting fluorescence X-rays generated from the surface of samples irradiated with X-rays. They can be used to easily and non-destructively analyze samples in a wide range of forms, including solids and powders. The EDX-7000 and EDX-8000 energy... Read more

August 29, 2017 Acad, Gov/Utilities Molecular Spectroscopy

Leica FL560 achieves First FDA Clearance for cerebrovascular fluorescence with fluorescein

View of an Arteriovenous Malformation (AVM) viewed with FL560 fluorescence. Photo courtesy of Cleopatra Charalampaki, MD, PhD, Professor of Neurosurgery, Department of Neurosurgery, Cologne Medical Center, Germany Leica Microsystems is proud to be the first company to attain FDA 510(k) clearance for its FL560 fluorescence microscope filter for visualization of cerebrovascular blood flow in conjunction... Read more

August 28, 2017 Acad, Gov/Utilities

FDA grants Priority Review for Roche’s Gazyva in previously untreated follicular lymphoma

Basel, 28 August 2017 FDA grants Priority Review for Roche’s Gazyva in previously untreated follicular lymphoma Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Gazyva® (obinutuzumab) in combination with chemotherapy followed by Gazyva... Read more